Actos Lawsuit | Actos Bladder Cancer Lawsuit Illinois

Tennessee Plaintiff Files Actos Lawsuit in Illinois Court

Staff Writer | March 30th, 2012

On March 9, 2012, Charles Edward White, a resident of Tennessee, filed an Actos side effects lawsuit in the Circuit Court of Cook County, Illinois. According to his Actos lawyer, the plaintiff was diagnosed with Actos bladder cancer as a direct result of taking the diabetes medication. White asks the court for compensation of his injuries.

Plaintiff suffers from Actos bladder cancer

Type II diabetes, the most common form of diabetes, occurs when the body does not produce sufficient insulin and does not use efficiently the insulin it does produce. Enter Actos, an insulin-sensitizing medication first approved by the U.S. Food and Drug Administration (FDA) in July 1999 to treat type II diabetes.

However, according to White’s Actos lawyer, the drug does more than just stabilize a patient’s insulin levels: “As a result of the defective nature of Actos, persons who were prescribed and ingested Actos for more than twelve months, including Plaintiff, were at increased risk for developing bladder cancer, [and] have suffered … from bladder cancer.”

Actos side effects lawsuit claims wanton malice

A principal allegation in White’s lawsuit is that Takeda “willfully, wantonly and with malice” concealed their knowledge of bladder cancer risks, specifically in patients who took the drug for more than 12 months.

The plaintiff’s Actos lawyer cites several studies and other evidence to support this allegation, among them a two-year carcinogenicity study that was conducted prior to Actos’ FDA approval, which indicated that male rats receiving Actos developed drug-induced tumors.

In 2005, results from the PROspective PioglitAzone Clinical Trial in MacroVascular Events (PROactive) study indicated that there was a significantly higher risk of bladder cancer in patients taking Actos than in those taking similar drugs, yet neither Takeda nor the researchers publish these findings. White’s Actos lawyer contends that the plaintiff developed Actos cancer as a proximate result of these acts and omissions.

Actos lawyer requests compensation

On or around February 2007, the plaintiff was prescribed and began taking Actos for long-term maintenance of his Type II diabetes. He stopped taking the drug around July 2009, but it was already too late: in October 2009, White alleges that he was diagnosed with Actos cancer.

Prior to June 2011, the plaintiff states he was unaware of the risk of bladder cancer, but had he understood the possibility, he would never have taken Actos. He claims permanent and severe injuries, as well as ongoing requirements for medical care and treatment.

Plaintiff White allegedly suffers severe mental and physical pain, has sustained emotional distress, and has experienced economic loss due to his medical expenses. His Actos lawyer charges Takeda with strict liability and negligence, and requests related damages.